IR could also promote alpha-synuclein accumulation and disrupt insulin signaling in dopaminergic neurons, leading to dopaminergic dysfunction, reduced mitochondrial oxidative activity, and ultimately, the onset and progression of PD (Athauda and Foltynie, 2016). The gene discussed is SNCA; the disease is Parkinson disease.